Cargando…
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation
The coronavirus disease 2019 (COVID-19) has spread widely around the world and has seriously affected the human health of tens of millions of people. In view of lacking anti-virus drugs target to SARS-CoV-2, there is an urgent need to develop effective new drugs. In this study, we reported our disco...
Autores principales: | Xiao, Ting, Cui, Mengqi, Zheng, Caijuan, Wang, Ming, Sun, Ronghao, Gao, Dandi, Bao, Jiali, Ren, Shanfa, Yang, Bo, Lin, Jianping, Li, Xiaoping, Li, Dongmei, Yang, Cheng, Zhou, Honggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248548/ https://www.ncbi.nlm.nih.gov/pubmed/34220507 http://dx.doi.org/10.3389/fphar.2021.669642 |
Ejemplares similares
-
Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M(pro) and Sepsis in Mice
por: Xiao, Ting, et al.
Publicado: (2021) -
Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis
por: Xiao, Ting, et al.
Publicado: (2021) -
Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
por: Yang, Hui-Wen, et al.
Publicado: (2023) -
Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models
por: Li, Jie, et al.
Publicado: (2021) -
Myricetin Induces Autophagy and Cell Cycle Arrest of HCC by Inhibiting MARCH1-Regulated Stat3 and p38 MAPK Signaling Pathways
por: Yang, Wei, et al.
Publicado: (2021)